# Analysis of influenza A, influenza B and Mycoplasma pneumoniae infection in children hospitalized with acute respiratory tract infection in Xi’an from 2021 to 2023

**Authors:** Haijin Zhang, Guihua Zhuang, Bingtong Zhao, Zengguo Wang

PMC · DOI: 10.3389/fpubh.2026.1762939 · 2026-03-06

## TL;DR

This study analyzed the presence of three pathogens in children hospitalized with respiratory infections in Xi’an from 2021 to 2023, finding significant changes in infection rates over time.

## Contribution

The study provides updated epidemiological data on FluA, FluB, and Mp infections in children with ARTI in Xi’an over a three-year period.

## Key findings

- Mycoplasma pneumoniae was the most frequently detected pathogen, with a detection rate of 30.14%.
- FluA detection increased significantly from 0.53% in 2021 to 12.90% in 2023.
- Co-infection rates rose from 0.75% in 2021 to 2.38% in 2023.

## Abstract

To evaluate the occurrence of three pathogens, influenza virus A (FluA), influenza virus B (FluB) and Mycoplasma pneumoniae (Mp) in children hospitalized with acute respiratory tract infection (ARTI) between 2021 and 2023.

FluA, FluB and Mp were detected by antigen/antibody kit in specimens from 29,014 children with ARTI admitted to Xi’an Children’s Hospital.

The total pathogen detection rate was 43.79% (12,707/29014) with 30.14% (8,745/29014) Mp-positive cases, 7.08% (55/29014) FluA-positive and 6.57% (1907/29014) FluB-positive. Total detection rates were 28.05% (2,472/8813) in 2021, 29.38% (2,550/8680) in 2022 and 66.70% (7,685/11521) in 2023. Co-infection rates with two or more pathogens increased over the period of interest from 0.75% (66/8813) in 2021, 0.93% (81/8680) in 2022 to 2.38% (274/11521) in 2023 (χ2 = 115.931, p < 0.001). FluA detection also increased and was present in 0.53% cases in 2021, 6.01% in 2022 and 12.90% in 2023, reaching a peak in February 2023 of 17.83% and March 2023 of 64.42%. FluB detection rates were more stable at 5.25% in 2021, 7.67% in 2022 and 6.75% in 2023, reaching a peak of 22.17% in December 2023. Mp detection was higher in 2023 at 47.05% with a peak of 82.21% in October 2023 than in 2021 (15.89%) or 2022 (15.69%). More FluA-positive cases were seen in the >12 age groups than in younger children and FluB detection also increased with age. Mp infection was detected in the >4 age group.

The pathogen spectrum and epidemiology of ARTI changed between 2021 and 2023. Age-specific bandings of infection were seen in the cohort of children. Outbreaks of FluA, FluB and Mp influence the pathology of ARTI.

## Full-text entities

- **Genes:** NEU1 (neuraminidase 1) [NCBI Gene 4758] {aka NANH, NEU, SIAL1}
- **Diseases:** respiratory (MESH:D012131), COVID-19 (MESH:D000086382), congenital genetic disorders (MESH:D030342), Co (MESH:D060085), fever (MESH:D005334), sore throat (MESH:D010612), Influenza (MESH:D007251), cough (MESH:D003371), myalgia (MESH:D063806), malignant tumors (MESH:D009369), hemolysis (MESH:D006461), immunodeficiency diseases (MESH:D007153), headache (MESH:D006261), death (MESH:D003643), Mp pneumonia (MESH:D011014), rhinorrhea (MESH:D012818), ARTI (MESH:D012141), FluA infections (MESH:D007239), Mp (MESH:D011019)
- **Chemicals:** Gold (MESH:D006046), FluA (-)
- **Species:** Respiratory syncytial virus (no rank) [taxon 12814], Mycoplasmoides pneumoniae (Filterable agent of primary atypical pneumonia, species) [taxon 2104], H3N2 subtype (serotype) [taxon 119210], Alphainfluenzavirus (genus) [taxon 197911], Betainfluenzavirus (genus) [taxon 197912], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]

---
Source: https://tomesphere.com/paper/PMC13002786